Searched for
RAJESH LADDHA
HC discharges Gautam Adani, Rajesh Adani in market regulations 'violation' caseThe Bombay High Court on Monday discharged Adani Enterprises Ltd, group Chairman Gautam Adani and MD Rajesh Adani from a case of alleged vi...- Bombay HC discharges Gautam Adani and Rajesh Adani in alleged Rs 388 cr market regulation violation caseThe Bombay High Court has discharged Gautam Adani and Rajesh Adani from charges related to market regulation violations involving Rs 388 cr...
- Piramal Capital to raise up to Rs 1,000 crore via NCDsThe tenors of NCDs are 26 months, 36 months, 60 months and 120 months, with coupons in the range of 8.1 per cent to 9 per cent on an annual...
- Piramal Investment Advisory Services, 4 others settle case with SebiThe regulator agreed to settle proposed adjudication proceedings in the case, pertaining to alleged violation of various provisions of the ...
- Piramal Capital reduces share of short-term borrowingsShort term borrowings now form just about 15-20 percent of total borrowings of the financial services business under Piramal Enterprises, c...
- Piramal Capital & Housing raises Rs 4,050 crore via NCDsPCHFL, a wholly owned subsidiary of Piramal Enterprises, sold bonds in two tranches earlier in the month.
- SC approves nine advocates’ elevation as judges at Bombay HC including Somasekhar SundaresanAmong the advocates who have been elevated to the bench include Somasekhar Sundaresan, Aruna S Pai, Shailesh P Brahme, Kamal R Khata, Sharm...
- Ajay Piramal, Shriram Capital name finance business CEO, scotch discontent rumoursPiramal Enterprises picked up stakes across Shriram group cos between 2013 and 2015, including a 20% buy in Shriram Capital, paving the way...
- Shriram Capital appoints Rajesh Laddha as new MD and CEORajesh Laddha was also part of the core team at Piramal Group that was involved in the purchase of its strategic stake in Shriram Group com...
- Ajay Piramal to hike stake in Shriram CapitalA hike in Piramal shareholding could pave way for the merger of Shriram Capital with the financial services business of PEL, creating India...
- Budget 2014 a pragmatic & balanced one, says Rajesh Laddha of Piramal EnterprisesThe new government has probably tried to balance the fiscal deficit restrictions vis a vis the push to be provided to the ailing economy.
- Piramal buys 10% in Shriram Transport for Rs 1,652 croreWhen asked why only 10 per cent, Laddha said only a block was available in the market, adding the company is looking for similar inorganic ...
- Bought 10% stake in STFC via secondary market: Rajesh Laddha, Piramal Enterprises"We bought about 10% stake in Shriram Transport Finance Company Ltd. This was done on the floor of the stock exchange."
- Five ways to deal with habitual procrastinatorsLast year, Rajesh Laddha, group CFO of Piramal Group saw one of his procrastinator reportees quit. Dealing with procrastinators can be a ch...
- Ajay Piramal relies on four teams to scout for buys in pharma, life sciences & real estateIndUS Growth Partners is one of the four entities that Piramal has created to identify opportunities for M&A across sectors.
- Piramal buys to get board representation in VodafoneThe Piramal Healthcare group will get a board seat after its purchase of additional 5.5% in Vodafone India.
- Ajay Piramal's problem of plenty: Market wants Piramal to start dealing with cash chest of Rs 10,000 croreThe market wants Ajay Piramal to quickly choose his new businesses and start dealing his flagship's cash chest of Rs 10,000 crore.
- Piramal Healthcare to buy 5.5% in Vodafone Essar for $640 millionPiramal Healthcare has agreed to buy 5.5% stake in Vodafone Essar, one of India's largest telecom companies, for $640 million.
- Piramal Health to receive USD 2.12-bn in 4-6 weeks from AbbottAjay Piramal-controlled Piramal Healthcare expects to get USD 2.12-billion in 4-6-weeks following completion of the sale transaction of its...
- Piramal buys Cipla's i-pill for Rs 95 crorePiramal Healthcare bought Cipla’s oral contraceptive brand, i-pill, for Rs 95 crore, to achieve its target of trebling its over-the-counter...
Load More
